Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Shawver LK, et al. Anti-neoplastic drugs in cancer therapy. US Patent 6,123,939 dated Sep 26 2000
Hancock MC, et al. A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity. Cancer Res. 51: 4575-4580, 1991. PubMed: 1678683
